EE121 Cost-Efficiency and the Opportunity for Expanded Treatment Access with Incremental Increases in Biosimilar Adalimumab and Tocilizumab Use: A European Perspective
Dec 1, 2023, 00:00
10.1016/j.jval.2023.09.391
https://www.valueinhealthjournal.com/article/S1098-3015(23)03521-0/fulltext
Title :
EE121 Cost-Efficiency and the Opportunity for Expanded Treatment Access with Incremental Increases in Biosimilar Adalimumab and Tocilizumab Use: A European Perspective
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(23)03521-0&doi=10.1016/j.jval.2023.09.391
First page :
Section Title :
Open access? :
No
Section Order :
12418